The company says the system can benefit pharmaceutical and biotech firms seeking rapid feedback on drug candidates or genome editing.
Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...
A man with neurofibromas who didn't know he's been clinically diagnosed with NF1, learns he harbors a deeply intronic, likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback